Septic arthritis: What is the role for the rheumatologist?;Artrite settica: Il ruolo del reumatologo

Reumatismo

Volumn 60, Issue 1, 2008, Pages 1-5

  Schiavon, Franco ^a   Favero, M ^a   Carraro, V ^a   Riato, L ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anti TNF therapy; Septic arthritis; Synovial fluid analysis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AGING; ANKYLOSING SPONDYLITIS; BACTERIAL ARTHRITIS; DISEASE PREDISPOSITION; EDITORIAL; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFECTIOUS ARTHRITIS; JOINT DESTRUCTION; JOINT PROSTHESIS; MORBIDITY; MORTALITY; NEEDLE BIOPSY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SURGICAL DRAINAGE; SYNOVIAL FLUID; UNITED KINGDOM;

ARTHRITIS, INFECTIOUS; EARLY DIAGNOSIS; HUMANS; PHYSICIAN'S ROLE; RHEUMATOLOGY;

EID: 49249117753     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (40)

1. Smith JW, Chalupa P, Shabaz-Hasan M. Infectious arthritis: Clinical features, laboratory findings and treatment. Clin. Microbiol Infect. 2006; 12: 309-14.
2. Reilly PA, Cosh GA, Maddison PJ, Rasker JJ, Silmann AJ. Mortality and survivial in rheumatoid arthritis: A 25 years prospective study of 100 patients. Ann Rheum Dis 1990; 49: 363-9.
3. Goldenberg DL, Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 1989; 32: 496-502
4. Edwards CJ, Cooper C, Fisher D, Field M. Van Staa TP, Arden N. The importance of the disease process and disease-modifyng antirheumatic drug treatment in the development of septic arthritis in patient with rheumatoid arthritis Arthritis Rheum 2007; 57: 1151-7.
5. Gluck T, Klefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. immune status and risk for infection in patients receiving chronic immunosoppressive therapy. J Rheumatol 2005; 32: 1473-80.
6. Doran M F, Crowson CS, Pond GR, O'Fallon M, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthritis Rheum 2002; 46: 2287-93.
7. Listing J., Strangfeld A, Kary S Rau R, von Hiueber U, Stoyanova-Scholz M, et al. Infection in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005; 52: 3403-12.
8. Stranfels A, Listing J. Bacterial and opportunistic infections during anti TNF therapy Best Pract. Res Clin Rheumatol 2006; 20: 1181-95.
9. Kaandorp CJE, Krijnen P, Moens HJB, Habbema JDF, Van Schaanderburg D. The outcome of bacterial arthritis: A prospective community-based study. Arthritis Rheum 1997; 40: 884-92.
10. Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiere JL, Sauvezie B. No change in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis 2002; 61: 267-9.
11. Dobost JJ, Soubrier M, Sauvezie B. Pyogenic arthritis in adults. Joint Bone Spine 2000; 67: 11-21.
12. Weston VC, Jones AC, Bradbury N, Fawthrop F, Dohery M. Clinical features and outcome of septic arthritis in a single UK health district 1982-1991. Ann Rheum Dis 1999; 58: 214-9.
13. Baer PA, Tenenbaum J, Fam G, Little H. Coexistence septic and crystal arthritis. Report of four cases and literature review. J. Rheumatol 1986; 13: 604-7.
14. Ilhai OA, Swarna U, Hamill RJ, Young EJ, Tullo HS. Concomitant crystal and septic arthritis Orthopedics 1996; 19: 613-7.
15. Cooper C, Cawley M Bacterial arthritis in the elderly. Gerontology 1986; 32: 222-7.
16. Gavet F, Tournade A, Soubier M, Ristori JM Dobost JJ. Septic arthritis in patients aged 80 and older: A comparison with younger adults. J Am Geriatr Soc 2005; 53: 1210-3.
17. Zimmerli W, Trampuz A, Ochsner P. Prosthetic joint infections. N Engl J Med 2004; 351: 1645-54.
18. Lidgren L, Knutson K, Stefandottir A. Infection of prosthetic joint. Best Pract Res Clin Rheumatol 2003; 17: 209-18.
19. Hackson MS, Bagg J, Gupta MN, Sturrock RD Oral carriage of staphylococci in patients with rheumatoid arthritis. Rheumatology 1999; 38: 572-5.
20. Zimmerli W. Prosthetic-joint associated infections. Best Pract Res Clin Rheumatol 2006; 20: 1045-63.
21. Hermann M, Vaudaux PE, Pittet D, Auckenthaler R Lew PD, Schumacher-Perdreau F, et al Fibronectin, fibrinogen, and laminin acts as mediator of adherence of clinical staphylococcal isolates to foreign material. J infect Dis 1998; 158: 693-701.
22. Shirliff ME, Mader JT. Acute septic arthritis. Clin Microbol Rev 2002; 15: 527-44.
23. Tarkowsky A, Bokarewa M, Collins LV, Gjertsson I, Hultgren OH, Jin T, et al Current status of pathogenetic mechanisms in staphylococcal arthritis. FEMS Mycrobiol Lett 2002; 217: 125-32.
24. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flega KM, Engelgau MM, et al prevalence of diabetes glucose in adults in the U.S. population Diabetes care 2006; 29: 1263-8.
25. Cunnane G, Doran M, Bresnhian B. Infections and biological therapy in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol 2003; 17: 345-63.
26. Osiri M, Ruxruhngtham S, Nookhai S, Ohomoto Y, Deesomchok U. IL-1 beta, Il-6, and TNF alpha in synovial fluid of patients with non gonococcical septic arthritis. Asian Pac J allergy Immunol 1998; 16: 155-60.
27. Dixon WG, Watson K, Lunt M, Hyric KL, Silman AJ, Symmons DPM. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Arthritis Rheum 2006; 54: 2368-76.
28. Curtis JR. Patkar N, Xie A, Martin C Allison JJ Saag M, et al. Risk of serious infections among rheumatoid arthritis patients exposed to tumor necrosis factor antagonists. Arthritis Rheum 2007; 56: 1125-33.
29. Salliot C, Gossec L, Ruyssen-Witrand A, Luc M, Duclos M, Guignard S, et al. Infections during tumour necrosis factor-α blocker therapy for rheumatic diseases in daily practice: A systematic retrospective study of 709 patients. Rheumatology 2007; 46: 327-34.
30. Tarkosky A. Infectious arthritis. Best Pract Res Clin Rheumatol 2006; 20: 1029-44.
31. Gupta MN, Sturrock RD, Field M. Prospective comparative study or patient with culture proven and high suspicion of adult onset septic arthritis Ann Rheum Dis 2003; 62: 327-31.
32. Punzi L, Cimmino M, Frizziero L, Gerloni V, Grassi W, Modena V, et al Italian society of Rheumatology (SIR) recommendations for performing arthrocentesis. Reumatismo 2007; 59: 228-34.
33. Li SF, Cassidy C, Chang C, Gharib S, Torres J. Diagnostic utility of laboratory tests in septic arthritis Emerg. Med 2007; 24: 75-7.
34. Trampuz A, Hanssen AD, Osmon DR, Mandekar J, Steckelberg JM, Patel R. Synovial fluid leucocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117: 556-62.
35. Streit G, Alber D, Toubin MM, Toussirot E, Wendling D. Procalcitonin, C-reactive protein and complement C3-a assays in synovial fluid for diagnosing septic arthritis: Preliminary results. Joint Bone Spine 2007 in press.
36. Grassi W, Farina A, Filippucci E, Cervini C. Sonographically guided procedures in Rheumatology. Sem Arth Rheum 2001; 30: 347-53.
37. Costantino TG, Roemer B, Leber EH. Septic arthritis and bursitis: emergency ultrasound can facilitate diagnosis. J Emerg Med 2007; 32: 295-7.
38. Hakki S, Harwood SJ, Morissey MA, Camblin JG, Laven DL, Webster WB Jr. Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Clin Orthop Rel Res 1997; 335: 275-85.
39. Mathews CJ, Kingsley G, Field M, Jones A, Weston VC, Philipps M et al. Management of septic arthritis: A systematic review. Ann Rheum Dis 2007; 66: 440-5.
40. Berendt T, Byren I. Bone and joint infection. Clin Med 2004; 6: 510-8.